Categories: Business

WLFI Partners with AB to Deploy the USD1 Stablecoin on AB Chain

SINGAPORE, Nov. 13, 2025 /PRNewswire/ — World Liberty Financial (WLFI) and AB Chain announced a collaboration under which USD1 has been deployed on AB Chain. Leveraging AB Chain’s high-performance network, USD1 delivers a faster and more convenient stablecoin experience for users.

- Advertisement -

The partnership further enriches AB Chain’s DeFi and payments ecosystem, strengthening use cases across trading, lending, and liquidity.

- Advertisement -

Meanwhile, the decentralized wallet AB Wallet aims to be the most user-friendly wallet for USD1 with zero-fee transfers, near-instant settlement, and full compatibility with all chains where USD1 is available. Looking ahead, AB Wallet is exploring USD1 yield and other value-added services.

- Advertisement -

The launch of USD1 marks an important step forward in AB Chain’s stablecoin infrastructure.

- Advertisement -

Learn more:
WLFI: www.worldlibertyfinancial.com
WLFI official X (Twitter): https://x.com/worldlibertyfi
AB DAO: www.ab.org
AB DAO official X (Twitter): https://x.com/ABDAO_Global
AB Charity Foundation: www.abfdn.org

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/wlfi-partners-with-ab-to-deploy-the-usd1-stablecoin-on-ab-chain-302614449.html

- Advertisement -
PRNW Agency

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

1 week ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

2 weeks ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

3 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

3 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

2 months ago